Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vibrio cholerae is a Gram-negative bacterium that causes cholera, a severe diarrheal disease. Only toxigenic strains from serogroups O1 and O139 are responsible for epidemic and pandemic cholera. The primary virulence factor is cholera toxin (CTX), which causes profuse watery diarrhea. Treatment involves antibiotics and oral rehydration salts.
Antibiotics target bacterial cell wall synthesis, protein synthesis, or DNA replication. Oral rehydration salts replenish fluids and electrolytes lost due to diarrhea.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vibrio cholerae (O1 and O139) (V. cholerae).